Evidence map›Paper›PMID 32358510›Full record

SynthesisInternational journal of impotence research2021

A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements.

Manish Kuchakulla, Manish Narasimman, Yash Soni, Joon Yau Leong, Premal Patel, Ranjith Ramasamy

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in International journal of impotence research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Medicina (Kaunas, Lithuania) · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Multifaced Nature of Yohimbine-A Promising Therapeutic Potential or a Risk?International journal of molecular sciences · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manish KuchakullaDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.ORCID http://orcid.org/0000-0003-2238-6752
Manish NarasimmanDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.
Yash SoniDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.
Joon Yau LeongDepartment of Urology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-1698-8442
Premal PatelUniversity of Manitoba, Winnipeg, MB, Canada.
Ranjith RamasamyDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA. Ramasamy@miami.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective was to study available evidence for ingredients of popular over-the-counter testosterone and erectile dysfunction (ED) supplements. The top 16 male testosterone and 16 ED supplements in the USA were identified from the most popular online retailers: A1 Supplements, Amazon, Vitamin Shoppe, and Walmart. In total, 37 ingredients were identified and PUBMED online database was reviewed for randomized-controlled trials (RCT) studying their efficacy. Ingredients were categorized based on evidence quantity using an adapted version of the American Heart Association scoring system. In total, 16 ingredients from testosterone supplements and 21 from ED supplements were identified. Tribulus, Eurycoma longifolia, Zinc, L-arginine, Aspartate, Horny goat weed, and Yohimbine were most common. In all, 105 RCTs studying the identified ingredients were found. No whole supplement products have published RCT evidence. 19% of ingredients received an A grade for strong positive evidence with net positive evidence in two or more RCTs. In total, 68% received C or D grades for contradicting, negative, or lacking evidence. Overall, 69% of ingredients in testosterone supplements and 52% of ingredients in ED supplements have published RCT evidence. Many male supplements claim to improve testosterone or ED parameters; however, there is limited evidence, which should be considered when counseling patients.

Indexed as

Erectile DysfunctionArginineDietary SupplementsHumansMalePlant ExtractsTestosteroneArgininePlant ExtractsTestosterone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.